- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04432129
Integrated Mental Health Care and Vocational Rehabilitation to People With to Common Mental Disorders (IBBIS II)
Integrated Mental Health Care and Vocational Rehabilitation Intervention to Individuals on Sick Leave Due to Anxiety, Depression, Personality Disorders, Stress and Functional Disorders
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Mental illness has an estimated financial burden on the Danish economy of 3.4 % of Gross National Product every year due to lost productivity, social benefits and healthcare costs and approximately 50 % of people receiving long-term sickness benefits have a common mental illness. Furthermore, a significant treatment gap exists where less than 30% were treated for their mental illness.
Objective:
The primary objective of the randomized trial is to examine whether people on sick leave with a diagnosis of anxiety, depression, stress, personality disorders or functional disorders, return to work faster and have a higher job retention if they receive an integrated and optimized vocational rehabilitation and mental health care intervention, compared to people who receive the standard mental health care and vocational rehabilitation service.
Method:
The trial is designed as an randomized, two-group parallel, assessor-blinded, multisite trial. A total of 800 participants with a common mental illness will randomly be assigned into two groups 1) IBBIS II, consisting of an integrated mental health care and vocational rehabilitation; or 2) Service as usual, at two sites in Denmark. The primary outcome is difference between the two groups in time to return to work at 12 months.
Results/discussion:
This study will contribute with new knowledge on vocational recovery and integrated vocational and health care interventions in a Scandinavian context.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2900
- Copenhagen Research Center for Mental Health - CORE
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Inclusion criteria
- Anxiety, depression, stress, personality disorder or functional disorder diagnosed at a structured diagnostic interview based on the Mini International Neuropsychiatric Interview conducted by the IBBIS team
- Sickness benefit recipient at baseline; on sick leave from job or unemployed for a minimum of four weeks
- Resident in Copenhagen or Aarhus municipalities
- Speak sufficient Danish to participate in interviews and complete questionnaires without an interpreter
- Aged 18 or older
- Has given informed written consent
Exclusion Criteria:
- Pregnant
- High degree of suicidal ideation
- Dementia
- Abuse of alcohol or other drugs to the degree that participation in therapy is not possible
- A need for mental health treatment in secondary sector care
- Unstable somatic condition that is too severe for participation in the project
- The participant will not refrain from participating in other psychotherapeutic treatment outside the IBBIS project if the participant will be allocated to the experimental group
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: IBBIS II
Integrated Mental Health Care and Vocational Rehabilitation
|
The IBBIS-II service consists of:
|
Active Comparator: Service As Usual
Standard vocational rehabilitation and treatment
|
Service as usual consists of standard mental health care and vocational rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Return to work
Time Frame: 12 months
|
Difference between the two groups in time to return to work from baseline until 12 months after baseline measured whit register based data.
Time to return to work is defined as a minimum of four weeks of continuous work without receiving sickness benefit.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Work at one point during follow-up
Time Frame: 12 months
|
Proportion in unsupported competitive work at 6 and 12-months follow up
|
12 months
|
Return to work
Time Frame: 6 months
|
Time to return to work from baseline until 6 months after baseline measured whit register based data
|
6 months
|
Supported work at one point during follow-up
Time Frame: 12 months
|
Proportion in supported work at 6 and 12-months follow up
|
12 months
|
Weeks of work
Time Frame: 12 months
|
Number of weeks in competitive employment from baseline to 6 and 12 months
|
12 months
|
Time to new sick leave
Time Frame: 12 months
|
The duration from return to work to potential new sick leave of more than 4 weeks within the 12-month follow-up period
|
12 months
|
Income
Time Frame: 12 months
|
Salary income from competitive employment at 6 and 12 months after baseline
|
12 months
|
Use of psychiatric services
Time Frame: 12 months
|
Number of admissions, inpatient days and outpatient contacts at the psychiatric hospitals at 6- and 12-months follow-up
|
12 months
|
Use of somatic services
Time Frame: 12 months
|
Number of admissions, inpatient days and outpatient contacts at the somatic hospitals at 6- and 12-months follow-up
|
12 months
|
Use of private health care
Time Frame: 12 months
|
Number of contacts with private health care professionals under the Health Insurance
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Lene F Eplov, PhD, Mental Health Center Copenhagen
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Version 3.1. 27.5.2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Personality Disorders
-
Icahn School of Medicine at Mount SinaiCompletedBorderline Personality Disorders | Avoidant Personality DisordersUnited States
-
University Hospital, Basel, SwitzerlandLeading House for the Latin American Region (Seed Money Grant SMG 1730)WithdrawnBorderline Personality Disorder (BPD)
-
University of Colorado, DenverCompleted
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline
-
NHS Greater Glasgow and ClydeUnknownBorderline Personality Disorder (BPD) | Antisocial Personality Disorder (ASPD)United Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingBorderline Personality Disorders | BPDSpain
-
Hospital Universitari Vall d'Hebron Research InstituteUnknownBorderline Personality Disorder.Spain
-
Universidad Nacional Autonoma de MexicoCompletedPsychopathic Personality TraitMexico
-
Silvia Elisa Hurtado SantiagoCompletedPersonality Disorder, BorderlineSpain
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline
Clinical Trials on IBBIS II
-
Mental Health Services in the Capital Region, DenmarkCopenhagen Municipality, Denmark; Municipality of Lyngby-Taarbæk, Denmark; Gladsaxe... and other collaboratorsCompletedDepression | Panic Disorder | Social Phobia | Generalized AnxietyDenmark
-
Mental Health Services in the Capital Region, DenmarkCopenhagen Municipality, Denmark; Municipality of Lyngby-Taarbæk, Denmark; Gladsaxe... and other collaboratorsCompletedBurnout | Adjustment Disorder | Psychological StressDenmark
-
Sun Pharmaceutical Industries LimitedMoebius Medical Ltd.; Nordic Bioscience Clinical Development (NBCD)CompletedOsteoarthritis of KneeUnited States, Denmark, Hong Kong
-
Sohag UniversityRecruitingNeonatal DeathEgypt
-
Guidant CorporationSuspended
-
University of California, Santa BarbaraCompleted
-
St. Olavs HospitalSmith & Nephew, Inc.Not yet recruitingArthroplasty | Arthritis Knee | Gait AnalysisNorway
-
Oregon Health and Science UniversityNational Institute on Aging (NIA)CompletedDementia | Alzheimer Disease | Relationship, Marital | Caregiver Stress SyndromeUnited States
-
Smith & Nephew, Inc.Active, not recruiting
-
Jarvik Heart, Inc.Recruiting